Tirzepatide is a dual GIP and GLP-1 receptor agonist under investigation for its effects on metabolic regulation, glucose control, and body composition. It is widely studied in models focused on insulin sensitivity and weight-related pathways.
✅ Investigated for glycemic control and appetite signaling
🧬 Dual receptor activity targeting GIP and GLP-1 pathways
💡 Commonly used in metabolic and body composition studies
Note: This compound is sold for research use only. Not for human consumption.
Reviews
There are no reviews yet.